Visomitin

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Apr 1, 2014 (NCT02121301)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • skq1
  • skq1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04206020Phase 3Dec 3, 2019Mitotech, SA, ORA, Inc.
NCT03764735Phase 3Oct 27, 2018Mitotech, SA, ORA, Inc.
NCT02121301Phase 2Apr 1, 2014Mitotech, SA, ORA, Inc.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Mitotech, SAFor profit3322014
ORA, Inc.For profit3022014
2 organizations
Page 1 / 1